Corrigendum to “CD161 receptor participates in both impairing NK cell cytotoxicity and the response to glycans and vimentin in patients with rheumatoid arthritis” [Clin. Immunol. 136 (2010) 139–147]

Autor: Richter, J., Benson, V., Grobarova, V., Svoboda, J., Vencovsky, J., Svobodova, R., Fiserova, A.
Zdroj: In Clinical Immunology March 2015 157(1):102-102
Databáze: ScienceDirect